SHL N Stock Overview
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 1/6 |
Dividends | 2/6 |
Siemens Healthineers AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €968.11 |
52 Week High | €1,177.98 |
52 Week Low | €968.11 |
Beta | 0.63 |
11 Month Change | 0% |
3 Month Change | -3.50% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -13.71% |
Recent News & Updates
Recent updates
Shareholder Returns
SHL N | MX Medical Equipment | MX Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how SHL N performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how SHL N performed against the MX Market.
Price Volatility
SHL N volatility | |
---|---|
SHL N Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: SHL N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SHL N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 70,100 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers AG Fundamentals Summary
SHL N fundamental statistics | |
---|---|
Market cap | Mex$1.17t |
Earnings (TTM) | Mex$29.40b |
Revenue (TTM) | Mex$418.20b |
39.7x
P/E Ratio2.8x
P/S RatioIs SHL N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SHL N income statement (TTM) | |
---|---|
Revenue | €21.61b |
Cost of Revenue | €13.94b |
Gross Profit | €7.67b |
Other Expenses | €6.15b |
Earnings | €1.52b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 02, 2023
Earnings per share (EPS) | 1.36 |
Gross Margin | 35.50% |
Net Profit Margin | 7.03% |
Debt/Equity Ratio | 65.2% |
How did SHL N perform over the long term?
See historical performance and comparison